Quinn Opportunity Partners’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-81,429
| Closed | -$397K | – | 365 |
|
|
2025
Q1 | $397K | Buy |
+81,429
| New | +$490K | 0.03% | 291 |
|
|
2024
Q4 | – | Sell |
-1,331
| Closed | -$13.8K | – | 380 |
|
|
2024
Q3 | $13.8K | Hold |
1,331
| – | – | ﹤0.01% | 282 |
|
|
2024
Q2 | $26.2K | Hold |
1,331
| – | – | ﹤0.01% | 276 |
|
|
2024
Q1 | $34.1K | Hold |
1,331
| – | – | ﹤0.01% | 249 |
|
|
2023
Q4 | $36.7K | Hold |
1,331
| – | – | ﹤0.01% | 228 |
|
|
2023
Q3 | $80.9K | Hold |
1,331
| – | – | 0.01% | 216 |
|
|
2023
Q2 | $87.6K | Sell |
1,331
-875
| -40% | -$64K | 0.01% | 193 |
|
|
2023
Q1 | $140K | Hold |
2,206
| – | – | 0.01% | 211 |
|
|
2022
Q4 | $305K | Hold |
2,206
| – | – | 0.04% | 147 |
|
|
2022
Q3 | $279K | Sell |
2,206
-770
| -26% | -$87.1K | 0.03% | 153 |
|
|
2022
Q2 | $246K | Sell |
2,976
-4,065
| -58% | -$315K | 0.02% | 173 |
|
|
2022
Q1 | $683K | Sell |
7,041
-500
| -7% | -$66K | 0.03% | 126 |
|
|
2021
Q4 | $1.51M | Sell |
7,541
-10,223
| -58% | -$2.41M | 0.09% | 124 |
|
|
2021
Q3 | $4.4M | Buy |
17,764
+1,166
| +7% | +$333K | 0.28% | 74 |
|
|
2021
Q2 | $6.88M | Sell |
16,598
-1,776
| -10% | -$704K | 0.43% | 49 |
|
|
2021
Q1 | $7.18M | Buy |
+18,374
| New | +$9.05M | 0.45% | 50 |
|
|
2018
Q1 | – | Sell |
-100
| Closed | -$232K | – | 206 |
|
|
2017
Q4 | $232K | Buy |
+100
| New | +$203K | 0.04% | 152 |
|
Other funds holding BLUE
Quinn Opportunity Partners's BLUE Position: Q2 2025 in Review
Quinn Opportunity Partners sold out of bluebird bio (BLUE) in Q2 2025, closing a stake of 81,429 shares — an estimated $397K sold.
Quinn Opportunity Partners first reported a position in BLUE in Q4 2017 and held it in 17 quarters. The position peaked at $7.18M in Q1 2021. 3 funds tracked by Wall St. Rank hold BLUE as of Q2 2025.
- Quinn Opportunity Partners reported no remaining bluebird bio position as of Q2 2025 after selling out during the quarter.
- Quinn Opportunity Partners sold 81,429 bluebird bio shares in Q2 2025, an estimated $397K.
- Quinn Opportunity Partners first reported a position in bluebird bio in Q4 2017 and held it in 17 quarters.
- Quinn Opportunity Partners's bluebird bio position peaked at $7.18M in Q1 2021.
- 3 funds tracked by Wall St. Rank held bluebird bio as of Q2 2025.
Based on Quinn Opportunity Partners's 13F filing for Q2 2025, filed 8 Aug 2025.